Projects

Voice 2 Diabetes (V2D)

Screening diabetes through voice analysis Voice 2 Diabetes is a patent-pending vocal biomarker algorithm that enables non-invasive, scalable screening for Type 2 diabetes using voice recordings. Developed by Klick Labs and validated through a peer-reviewed clinical study, V2D detects diabetes-related vocal changes with promising accuracy.

Now available as a licensable API, V2D can be integrated by NGOs, healthcare institutions, and industry partners to expand access to early detection tools—especially in low-resource settings.

This award-winning innovation has been recognized globally, earning awards such as the Cannes Lions Innovation Grand Prix, Grand LIA for Evolution, The One Show Best of Discipline, and Gold MM+M. It represents one of several vocal biomarker technologies in active development at Klick Labs.

LoveNet: Repurposing Drug Identification

LOVENet (Large Optimized Vector Embeddings Network) is a novel computational framework designed to enhance drug repurposing by integrating large language models (LLMs) with heterogeneous biomedical knowledge graphs. By combining semantic reasoning from natural language processing with topological insights from knowledge graphs, LOVENet aims to identify novel therapeutic indications for existing drugs.

Intubation Box

A simple solution to a complex global health challenge. The intubation box protects healthcare practitioners by shielding them from aerosolized COVID-19 particles during intubation. Boxes made by Klick were delivered to over 100 hospitals across North America during the early months of the pandemic.

HealthVoyager

Developed in collaboration with Boston Children’s Hospital, HealthVoyager gives patients a new way to interact with their health data. By providing findings in a personalized and approachable way, patients are now able to fully comprehend their individual results and connect with their healthcare providers in a new way.

SymPulse™

Traditionally symptom simulators for movement disorders like Parkinson’s were based around mechanical vibrations, but did not accurately simulate the symptom experience on a muscular level. Whereas Klick has developed technology that simulates the electrical muscle activity seen in movement disorder symptoms. In the past, feeling a loved one or patient’s tremors was an impossibility, but Klick’s SymPulse™ tele-empathy device has made that experience a reality.